Postoperative chemotherapy offers no benefit in high-risk squamous cell head and neck carcinoma

Weekly carboplatin did not confer any additional benefit when paired with postoperative radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck, according to findings from a randomised phase 3 study conducted in Australia and New Zealand.